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Direct and Indirect Excitation of Laterodorsal Tegmental Neurons
by Hypocretin/Orexin Peptides: Implications for Wakefulness
and Narcolepsy
Sophie Burlet, Christopher J. Tyler, and Christopher S. Leonard
Department of Physiology, New York Medical College, Valhalla, New York 10595

Compelling evidence links the recently discovered hypothalamic peptides Hypocretin/Orexin (Hcrt/Orx) to rapid eye movement sleep (REM) control and the sleep disorder narcolepsy, yet
how they influence sleep-related systems is not well understood. We investigated the action of Hcrt/Orx on mesopontine
cholinergic (MPCh) neurons of the laterodorsal tegmental nucleus (LDT), a target group whose function is altered in canine
narcolepsy and appears pivotal for normal REM and wakefulness. Extracellular recordings from mouse brainstem slices
revealed that Hcrt/Orx evoked prolonged firing of LDT neurons.
Whole-cell recordings revealed that Hcrt/Orx had actions on
both presynaptic neurons and at postsynaptic sites. Hcrt/Orx
produced an increase in frequency and amplitude of spontaneous EPSCs without equivalent effect on IPSCs, by triggering
action potentials and enhancing spike-evoked synaptic transmission in glutamatergic afferents. Postsynaptically, Hcrt/Orx
produced an inward current and an increase in membrane

current noise, which were accompanied by a conductance
increase. These persisted in TTX, ionotropic glutamate receptor
antagonists, and low extracellular calcium. Both presynaptic
and postsynaptic actions were specific because they were not
mimicked by an Hcrt/Orx fragment, and both actions were
observed for cholinergic and noncholinergic LDT neurons. Finally, extracellular recordings during postsynaptic potential
blockade demonstrated that postsynaptic actions of Hcrt/Orx
alone could evoke prolonged firing. In the context of other
recent work, our findings suggest that Hcrt/Orx neurons may
coordinate the activity of the entire reticular activating system
during waking. Moreover, these findings address specific hypotheses regarding the cellular mechanisms underlying REM
disregulation in narcolepsy.
Key words: REM sleep; orexin; hypocretin; narcolepsy; mesopontine cholinergic neurons; reticular formation; nitric oxide
synthase; whole cell; slice

The Hypocretin/Orexin (Hcrt/Orx) peptide system consists of
two peptides (Hcrt/Orx-A and Hcrt/Orx-B) derived from a single
prepro-peptide (de Lecea et al., 1998; Sakurai et al., 1998) and
two high-affinity G-protein-coupled receptors (Hcrt/OrxR1 and
Hcrt/OrxR2) (Sakurai et al., 1998) (for review, see Kilduff
and Peyron, 2000; Willie et al., 2001). Hcrt/Orx-synthesizing
neurons are localized to the lateral hypothalamus and were initially hypothesized to function in the control of feeding (de Lecea
et al., 1998; Sakurai et al., 1998). This system was linked recently
to the control of sleep and wakefulness by the surprising discovery that its genetic disruption produces narcolepsy (Chemelli et
al., 1999; Lin et al., 1999), a sleep disorder characterized by
excessive daytime sleepiness, sleep fragmentation, and the intrusion of rapid eye movement (REM) sleep behaviors into wakefulness (for review, see Nishino and Mignot, 1997). The loss of
Hcrt/Orx also appears central to human narcolepsy (Nishino et
al., 2000; Peyron et al., 2000; Thannickal et al., 2000).
A role for Hcrt/Orx neurons in behavioral-state control was
anticipated (Peyron et al., 1998) from their projection pattern,
which includes the locus ceruleus, the raphe nuclei, and the basal
forebrain and mesopontine cholinergic (MPCh) groups (Peyron

et al., 1998; Chemelli et al., 1999; Date et al., 1999; Horvath et al.,
1999; Nambu et al., 1999). Moreover, intracerebroventricular
delivery of Hcrt/Orx-A enhances arousal and reduces REM sleep
(Hagan et al., 1999; Piper et al., 2000), and significant Hcrt/OrxR
mRNA levels are found in locus ceruleus, the raphe nuclei, and
mesopontine cholinergic nuclei (Trivedi et al., 1998; Marcus et al.,
2001).
However, only limited information exits about the cellular
action of these peptides in the CNS. Activation of Hcrt/OrxRs
expressed in human embryonic kidney 293 cells increases intracellular calcium (Sakurai et al., 1998), and a similar effect was
demonstrated in cultured hypothalamic (van den Pol et al., 1998)
and spinal neurons (van den Pol, 1999). Hcrt/Orx-B also increases
both glutamatergic and GABAergic synaptic input (de Lecea et
al., 1998) to cultured hypothalamic neurons (van den Pol et al.,
1998). In brain slices, Hcrt/Orx excites locus ceruleus (Hagan et
al., 1999; Horvath et al., 1999) and dorsal raphe neurons (Brown
et al., 2001), and, in vivo, application in the locus ceruleus increases firing and enhances behavioral arousal (Bourgin et al.,
2000).
To further understand how this peptide system interacts with
brainstem systems controlling behavioral state, we investigated
the action of Hcrt/Orx on neurons of the laterodorsal tegmental
nucleus (LDT) in brain slices. Cholinergic neurons of this nucleus, and the adjacent pedunculopontine tegmental nucleus provide the major cholinergic input to the thalamus (for review, see
Wainer and Mesulam, 1990) and the medial pontine reticular
formation (mPRF) (Mitani et al., 1988). Activity of these neurons
is linked to REM sleep and arousal (for review, see Steriade and
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McCarley, 1990) and can profoundly influence thalamocortical
processing (Curro Dossi et al., 1991; Steriade et al., 1996). Moreover, studies on narcoleptic canines implicate these neurons in
generating the attacks of muscle atonia (cataplexy) characteristic
of this disorder (Reid et al., 1994a,b).
Our results demonstrate for the first time that Hcrt/Orx peptides excite both cholinergic and noncholinergic neurons of the
LDT by both direct actions and actions on their afferents. These
findings have implications for the role of the Hcrt/Orx system in
the control of wakefulness and for the neural mechanisms underlying REM sleep and cataplexy.
Parts of this work have been published previously in abstract
form (Burlet et al., 2000).

MATERIALS AND METHODS
Slice preparation and e xtracellular solutions. Brain slices were prepared
from 14- to 32-d-old C57BL /6 mice (Taconic, Germantown, N Y; Charles
River Laboratories, Wilmington, M A). All procedures complied with
National Institutes of Health and institutional guidelines for ethical use
of animals. After the induction of deep anesthesia with isofluorane, mice
were decapitated, and brains were rapidly removed into an ice-cold
artificial C SF (AC SF) that contained (in mM): 121 NaC l, 5 KC l, 1.2
NaH2PO4, 2.7 C aC l2, 1.2 MgSO4, 26 NaHC O3, 20 dextrose, and 4.2
lactic acid, oxygenated by bubbling with carbogen (95% O2 and 5%
C O2). The brainstem was blocked in a coronal plane, and vibratome
sectioned (V T1000S; Leica, Nussloch, Germany) into 350-m-thick sections. Slices containing the LDT were incubated at 35°C for 15 min in
oxygenated AC SF and were then stored at room temperature until they
were transferred to a submerged recording chamber, which was perf used
at 3–5 ml /min with oxygenated AC SF at room temperature. In some
experiments, calcium-dependent processes were inhibited by reducing
extracellular calcium to ⬃20 M (calculated with Patcher’s Power Tools
for Igor Pro; WaveMetrics, Lake Oswego, OR) by adding 2.7 mM EGTA
to the AC SF and elevating MgSO4 to either 3.9 or 6 mM.
Electrophysiolog ical recordings. Neurons were visualized (160 –200⫻)
with near-infrared light (⬎775nm) transillumination, using a nuvicon
tube camera (V E-1000; Dage-MTI, Michigan C ity, I N) and the differential interference contrast optics of a fixed-stage microscope (BX50W I;
Olympus Optical, Tokyo, Japan). C ells were selected for whole-cell
recording from a region identified as LDT at low magnification. Neurons
were recorded in voltage-clamp mode using an Axopatch 200A or B
amplifier (Axon Instruments, Foster C ity, CA). Giga-seal whole-cell
recordings (Hamill et al., 1981) were made with pipettes pulled from
1.5-mm-diameter glass capillary tubing (Corning 7052; A&M Systems,
C arlsborg, WA) using a horizontal multistep puller (P87; Sutter Instruments, Novato, CA). Voltage-clamp recordings were made to study
EPSC s using a pipette solution containing (in mM): 144 K-gluconate, 0.2
EGTA, 3 MgC l2, 10 H EPES, 0.3 NaGTP, and 4 Na2ATP. I PSC s were
recorded using an internal solution with KC l substituted for K-gluconate
so that I PSC s were inward at resting membrane potential. Biocytin
(0.1%) and Na-GTP were added to the pipette solution just before use.
“L oose-patch” (100 –300 M⍀) voltage recordings of extracellular activity
were made in current-clamp mode from somata of visualized neurons
with the same pipettes used for whole-cell recordings but were filled with
extracellular solution. Membrane currents and voltages were recorded
with respect to an Ag /AgC l reference electrode located near the outflow
of the chamber. Whole-cell liquid junction potentials were calculated to
be approximately ⫺12 mV for our internal solutions, and membrane
potentials were not corrected.
Membrane voltages and currents were controlled and recorded with a
computer running pC lamp8 software (Axon Instruments). Access resistance (Racc) was estimated on-line by exponential fitting of the uncompensated capacitative transients resulting from ⫾2.5 mV voltage steps
delivered at 3.3 Hz using the built-in membrane test routine of pC lamp8.
The quality of recorded cells were simultaneously assessed with this
routine by monitoring input resistance, holding current, and capacitance.
Parameters were monitored continuously over the initial several minutes
after establishing the whole-cell configuration and then again throughout
the experiment before and after each protocol. Recordings were terminated if the estimated Racc was ⬎30 M⍀, became unstable, or changed
by ⬎ 20% between measurements. Recordings were also terminated if
cell parameters became unstable. Recordings were uncompensated for
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series resistance errors because the recorded currents and associated
voltage errors were small. Voltage measurements were filtered at 10 kHz
with the four-pole Bessel filter at the amplifier output and sampled at 20
kHz, whereas EPSC s and I PSC s were filtered at 2 kHz and sampled at
5 kHz. Detection of PSC s and some analyses were done using Mini
Analysis software (Synaptosoft, Decatur, GA). To compare the effects of
Hcrt/Orx on the frequency and amplitudes of PSCs, epochs of at least 100
sec were used before, during, and after superfusion. Cumulative distributions of EPSCs or IPSCs were then compared using Kolmogorov–
Smirnov statistics with Mini Analysis software. Additional analysis and
figure preparation was done using Igor Pro software (WaveMetrics).
Differences between means were compared using a two-sample, twotailed t test corrected for multiple comparisons (when necessary) and
repeated-measures ANOVA using DataDesk 6 software (Data Description, Ithaca, N Y). Numerical results are reported as mean ⫾ SEM.
Spike-evoked EPSC s were elicited with single, near-minimal electrical
stimuli (0.1– 0.2 msec duration; 0.2– 0.33 Hz) from an optically isolated
stimulator (A35OD-A; World Precision Instruments, Sarasota, FL).
Stimuli were delivered with a bipolar tungsten microelectrode having a
single sharpened pole (TM33B01K T; World Precision Instruments) located ⬃1 mm in front of the other. The sharp end of the electrode was
positioned just below the slice surface ⬃30 –50 m from a proximal
dendrite of the recorded neuron. Stimulator voltage was increased until
an evoked EPSC (evEPSC) appeared. These typically had sharp thresholds, had a smooth rising phase that arose after a distinct delay, showed
little latency jitter, and showed significant amplitude fluctuations and
failures. To study the action of Hcrt /Orx, current strength was typically
increased to ⬃10% above threshold. This did not produce shape changes
in those evEPSC s examined and suggested that these arose from single
fibers. Amplitude distributions of 30 –50 consecutive evEPSC s were
compared statistically using Kolmogorov– Smirnov statistics. Average
values of evEPSC s were expressed as mean ⫾ SEM of these 30 –50
events.
Reagents. Orexin-B peptide was purchased from American Peptide
(Sunny vale, CA), and Orexin-A peptide was purchased from American
Peptide, Phoenix Pharmaceuticals (Mountain View, CA), and Sigma (St.
L ouis, MO). Peptides were applied by bath superf usion (at 10 nM, 100
nM, 300 nM, or 1 M). An amide fragment of Orexin-A (peptide sequence
16 –33; Phoenix Pharmaceuticals) was dissolved in normal AC SF and
superf used at 1 M as a control for nonspecific peptide actions. In some
experiments, TTX (0.5 M; Alomone Labs, Jerusalem, Israel) was added
to the recording solutions to block voltage-gated Na ⫹ channels. Ionotropic glutamate receptor antagonists 6,7-dinitroquinoxaline-2,3-dione
(DNQX) (15 M) and 2-amino-5-phosphonopentanoic acid (APV) (50
M), ionotropic GABA receptor antagonists picrotoxin (10 M) and
bicuculline (10 M), and the glycine receptor antagonist strychnine (2.5
M) were also used in some experiments (Sigma).
Immunohistochemistr y. Cholinergic neurons in the LDT selectively
colocalize the enzyme brain nitric oxide synthase (bNOS) (Vincent and
K imura, 1992) and were identified in this study by immunohistochemical
labeling for bNOS. Slices were fixed in 4% paraformaldehyde for 2–20 d
at 4°C, incubated in 30% sucrose in 0.1 M PBS overnight, and resectioned
at 40 m using a freezing microtome. Sections were incubated in avidin –
Texas Red (1:250 in PBS containing 0.3% Triton X-100; Vector Laboratories, Burlingame, CA) to visualize the recorded cell. Sections were
then incubated, in succession, in monoclonal bNOS antibodies (1:400 in
phosphate buffer containing 1% bovine serum albumin and 0.3% Triton
X-100 at room temperature; Sigma) and FI TC -conjugated goat antimouse IgGs (1:50 in PBS; Chemicon, Temecula, CA) to determine
whether recorded cells were bNOS immunoreactive. The sections were
mounted on glass slides, dried, dehydrated, and coverslipped, and then
48-bit color images were acquired using a cooled CCD camera (Coolsnap; Roper Scientific, Trenton, NJ) mounted on an epi-fluorescence
microscope (BX60; Olympus Optical) equipped with a 100 W mercury
illuminator. Fluorophores were visualized using the Chroma (Brattleboro, V T) HiQ FI TC (41001) and HiQ Texas Red (41004) filter sets.

RESULTS
Hypocretin/orexin stimulated repetitive firing in
LDT neurons
Initially, we evaluated possible actions of Hcrt/Orx using loosepatch extracellular recordings from the somata of visualized LDT
neurons. Neurons recorded in this manner had very low or zero
spontaneous firing rates (assessed over 100 sec). Bath application
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Figure 1. Hcrt/Orx stimulated a long-lasting increase in firing of LDT
neurons in vitro. A1, Extracellular loose-patch voltage recordings indicated that Hcrt/Orx-A (300 nM) stimulated even quiescent neurons to fire
repetitively. A2, Instantaneous spike rate of the neuron in A1 shows the
long-lasting Hcrt/Orx response. The bar over the histogram indicates the
duration of the superfusion in this and subsequent figures. B, Instantaneous firing rate from another neuron before and after two Hcrt/Orx
applications (1 M) shows that the second response was greatly attenuated. Note that the breaks in the time axis correspond to the time
between data files in this and subsequent figures.

of Hcrt/Orx-A (300 nM or 1 M; 1–2 min) produced a long-lasting
increase in firing in all cases (n ⫽ 15) (Fig. 1 A), driving even
quiescent neurons into repetitive firing. On average, 1 M Hcrt/
Orx increased firing from a baseline of 0.06 ⫾ 0.02 spikes/sec to
a peak of 1.02 ⫾ 0.22 spikes/sec (n ⫽ 6). We also noted that a
second application of Hcrt/Orx produced a response that was
smaller than the first, even after firing had recovered to near
baseline levels (Fig. 1 B), suggesting some form of use dependence or desensitization.

Hcrt/Orx-A and Hcrt/Orx-B excited bNOSimmunopositive LDT neurons by multiple actions
To investigate whether this excitation was mediated by presynaptic or postsynaptic mechanisms, whole-cell voltage-clamp recordings were obtained from the somata of 75 LDT neurons having a
mean input resistance of 356.1 ⫾ 24.4 M⍀ (range, 106.4 to 1100
M⍀). Hcrt/Orx-A or -B (1 M, n ⫽ 17; 300 nM, n ⫽ 7) was
superfused while neurons were held near resting potential (⫺60
mV) in the presence of picrotoxin (10 M 77) or bicuculline (10
M) and strychnine (2.5 M) to block spontaneous IPSCs. Under
these conditions, both peptides produced an increase in synaptic
activity and a small, slow inward shift in the holding current.
These effects are illustrated for a bNOS-immunopositive
(bNOS ⫹) LDT neuron in Figure 2 A in response to superfusion
of Hcrt/Orx-A (1 M). Brief epochs of membrane current from
before and after Hcrt/Orx application are illustrated below in
Figure 2, B and C, to show the synaptic activity more clearly.
These data also illustrate the slow inward current. Both the EPSC
activity and the inward current recovered by 22 min after Hcrt/
Orx-A application (Fig. 2 B3)
To quantify the effect of Hcrt/Orx on spontaneous EPSCs
(sEPSCs), cumulative amplitude and interval distributions were
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compared for each condition. For the example illustrated in
Figure 2, the average sEPSC amplitude increased from ⫺20.4 to
⫺33.6 pA ( p ⬍ 0.0001) (Fig. 2C, left), and the average interval
decreased from 418.1 to 101.6 msec ( p ⬍ 0.0001) (Fig. 2C, right),
verifying that the sEPSC frequency dramatically increased. This
increase in sEPSC frequency was typical of the cells recorded.
Hcrt/Orx-A at 1 M increased the frequency ( p ⬍ 0.001) for 12 of
12 cells (mean interval, 47.6 ⫾ 6.8% of control), and 1 M
Hcrt/Orx-B increased the frequency ( p ⬍ 0.001) for three of five
cells (mean interval, 56.2 ⫾ 3.0% of control). Moreover, 300 nM
Hcrt/Orx-A increased the mean frequency of sEPSCs for six of
seven neurons (mean interval, 50.7 ⫾ 8.6% of control) by an
amount not different from that produced by 1 M Hcrt/Orx. Thus,
at the two concentrations tested, Hcrt/Orx peptides doubled the
mean frequency of sEPSC in ⬎85% of LDT neurons.
In neurons that showed an increase in sEPSC frequency, the
average amplitude of the sEPSCs was also increased after both 1
M and 300 nM Hcrt/Orx to 134.3 ⫾ 9.3% (n ⫽ 15) and 110.0 ⫾
14.0% (n ⫽ 6) of control, respectively. However, an increase in
sEPSC amplitude was observed for only a subset of neurons. A
significant increase in mean sEPSC amplitude was found for nine
of 15 neurons tested with 1 M Hcrt/Orx-A and for two of six
neurons tested with 300 nM Hcrt/Orx-A. Thus, an increase in
mean sEPSC amplitude was not a prerequisite for an increase in
sEPSC frequency. In some neurons, recordings were long enough
to determine that these amplitude and frequency effects recovered after the washout of Hcrt/Orx (n ⫽ 6). The average amplitude and interval data for 1 M Hcrt/Orx are summarized in
Figure 2 D.
We confirmed that the stimulated EPSCs were glutamatergic in
experiments in which Hcrt/Orx was applied after ionotropic glutamate receptors were blocked (n ⫽ 4) (Fig. 2 E). Under these
conditions, Hcrt/Orx evoked an inward current but no PSCs. The
magnitude of the inward current produced by 1 M Hcrt/Orx-A
was ⫺17.3 ⫾ 2.7 pA (n ⫽ 12), whereas 1 M Hcrt/Orx-B produced
an average inward current of ⫺16.8 ⫾ 1.1 pA (n ⫽ 3). Similarly,
300 nM Hcrt/Orx-A produced an inward current of ⫺24.1 ⫾ 8.4
pA (n ⫽ 6), which was not different from that evoked by 1 M
Hcrt/Orx ( p ⫽ 0.34). These recordings also demonstrated that
there was a substantial increase in membrane current noise that
accompanied the inward current and was distinct from the fast
PSCs (Fig. 2 E). At its peak effect, 1 M Hcrt/Orx-A increased the
average rms noise to 133.4 ⫾ 9.1% of control (n ⫽ 12). Thus,
Hcrt/Orx peptides had multiple actions on LDT neurons.

Excitatory effects of Hcrt/Orx-A required the
full peptide
To test the possibility that these actions of Hcrt/Orx resulted from
a nonspecific effect of the peptide, we compared the actions in six
LDT neurons of the amide fragment of Orexin-A (16 –33), which
lacks the two intrachain disulfide bonds of the full peptide (Fig.
3). First the fragment (1 M) was superfused (Fig. 3A), and then
the full peptide (1 M) was superfused (Fig. 3B). None of the
fragment applications produced an increase in sEPSC frequency,
whereas each of the Hcrt/Orx-A applications resulted in a significant increase in sEPSC frequency (average mean interval, 58.5 ⫾
8.3% of control). Moreover, the average sEPSC amplitude increased after Hcrt/Orx application (138.8 ⫾ 20.8% of control) but
did not after fragment application (99.1 ⫾ 4.3% of control).
Unexpectedly, the fragment did produce a reduction in the average sEPSC frequency in three of six cases (average mean interval,
150.8 ⫾ 20.7% of control). We also found that the fragment did
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Figure 2. Hcrt/Orx produced an increase in glutamatergic synaptic activity, an inward current, and an increase in membrane current noise. A1, Whole-cell
recordings of membrane current at ⫺60 mV in the presence of bicuculline (10 M) and strychnine (2.5 M) indicate that Hcrt/Orx-A (1 M) application
produced a large increase in sEPSC activity and an inward shift of the baseline current that reversed after a washout of ⬃20 min. A2, Arrow indicates the
neuron whose currents are shown in A–C. The neuron was filled with biocytin during the recording and visualized with avidin–Texas Red epifluorescence.
A3, The same neuron was also visible with FITC immunofluorescence for bNOS. Scale bar (in A2): A2, A3, 25 m. B1, An expanded segment of the trace
in A1 before Hcrt/Orx application (labeled B1 in A1). B2, Expanded segment from A1 after Hcrt/Orx-A application illustrates the greater number of sEPSCs
and the inward current shift compared with baseline (horizontal dashed line). B3, These effects recovered by 20 min after the end of the Hcrt/Orx application.
C, Cumulative distributions of sEPSC amplitudes (left; Amp) and intervals (right; Int) from before (thin line) and after (thick line) Hcrt/Orx-A application.
Kolmogorov–Smirnov statistics demonstrated that Hcrt/Orx-A significantly increased both amplitude and frequency of sEPSCs. D, Population means of
sEPSC amplitudes (black bars) and inter-event intervals (white bars) from 15 LDT neurons expressed as percentage of control values. Each neuron showed
a significant reduction in the inter-event interval distribution after 1 M Hcrt/Orx-A. For six of these cells, sufficient recording time was available to observe
a recovery after washout of the peptide. E, EPSCs recorded in the presence of bicuculline and strychnine (left; BS) were entirely abolished by the addition
of DNQX and APV (middle; DABS). Subsequent application of Hcrt/Orx (300 nM) produced an inward current but no additional PSCs. A substantial
increase in current noise accompanied the inward current. Arrows point to expanded sections of the trace before and after Hcrt/Orx to illustrate the noise
at higher time resolution. The time scale in the middle also applies to the left. Note the different time scales in the right.

not evoke an inward current or increase in membrane noise,
whereas the full peptide did (⫺17.2 ⫾ 4.3 pA), as expected. Thus,
neither the sEPSP nor the inward current effect of Hcrt/Orx could
be attributed to a nonspecific peptide action.

Hcrt/Orx had less prevalent actions on inhibitory input
to LDT neurons
In a previous study of cultured hypothalamic neurons, Hcrt/
Orx-B was found to increase the frequency of miniature IPSCs
(mIPSCs) (van den Pol et al., 1998). We therefore tested the
effect of Hcrt/Orx-A and -B (1 M) on sIPSCs recorded from

LDT neurons (n ⫽ 13). Although effects on sIPSCs were observed, they occurred less commonly than the effects on sEPSCs.
For example, an effect of Hcrt/Orx on sIPSC amplitude was not
observed for any of the neurons studied, and an effect on sIPSC
frequency was only observed in approximately one-half the cells
(seven of 13; data not shown). Hcrt/Orx increased sIPSC frequency in four of 13 neurons (average mean interval, 61.4 ⫾
10.9% of control), whereas in three of 13 cells, Hcrt/Orx decreased the frequency (average mean interval, 184.1 ⫾ 11.8% of
control). Thus, Hcrt/Orx had a much more limited action on
inhibitory input to LDT neurons than on their excitatory inputs.
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Figure 3. Hcrt/Orx effects were specific for the full-length peptide.
Whole-cell voltage-clamp recordings (⫺60 mV) were obtained using a
K-gluconate internal solution and an extracellular solution containing
bicuculline (10 M) and strychnine (2.5 M). A, Application of the amide
fragment (16 –33) of Hcrt/Orx-A did not increase the frequency or amplitude of sEPSCs. B, In the same neuron recorded in A, subsequent
application of Hcrt/Orx-A produced the characteristic increase in both
sEPSC amplitude and frequency, as well as an inward shift in baseline
current. C, Average of mean inter-event intervals and amplitudes are
displayed for a population of six LDT neurons exposed first to the peptide
fragment and then Hcrt/Orx-A. Means are expressed as percentage of
control values.

The Hcrt/Orx-evoked increase in EPSC activity was
sensitive to TTX
To determine whether the Hcrt/Orx-evoked increase in sEPSC
activity depended on the generation of Na ⫹-dependent action
potentials, we tested the effect of Hcrt/Orx on spontaneously
occurring EPSCs after application of TTX (mEPSCs; 0.5 M) on
nine neurons (n ⫽ 4, internal K-gluconate; n ⫽ 5, internal KCl).
In neurons recorded with internal gluconate, Hcrt/Orx-A (1 M)
had no effect on amplitude or frequency distributions of mEPSCs
in three of four neurons tested, although it produced an inward
current accompanied by an obvious increase in membrane noise
(Fig. 4 A). Indeed, the noise increase in these neurons was large
enough to obscure the smallest EPSCs discernable before Hcrt/
Orx application. Thus, to avoid contamination, the smallest
EPSCs were excluded from the analysis. To extend the analysis to
a fuller range of EPSC amplitudes, we took advantage of the
observation made while recording IPSCs that the Hcrt/Orxevoked noise, and the inward current were greatly attenuated
using the KCl internal solution. Although we did not further
investigate the mechanism, this presumably resulted from the
high intracellular [Cl ⫺] interfering with G-protein modulation of
ionic conductances (Lenz et al., 1997). Five neurons were re-
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corded under these conditions in the presence of TTX (0.5 M),
and we found that, whereas the EPSCs were similar to those
measured with K-gluconate, Hcrt/Orx-A had no effect on EPSC
frequency or amplitude in these recordings (Fig. 4 B).
Overall, when compared with control values, neither the average mean amplitude (98.6 ⫾ 3.2%, p ⫽ 0.52, K-gluconate; 108.4 ⫾
5.7%, p ⫽ 0.23, KCl) nor the average mean interval (91.6 ⫾
16.9%, p ⫽ 0.75, n ⫽ 4, K-gluconate; 94.5 ⫾ 6.0%, p ⫽ 0.34, n ⫽
5, KCl) were different after Hcrt/Orx application (Fig. 4C). In the
single case in which Hcrt/Orx increased the frequency, it had no
effect on mEPSC amplitude. Thus, TTX blocked the Hcrt/Orx
effect on EPSC frequency and amplitude in eight of nine neurons,
indicating that action potentials were typically required for the
Hcrt/Orx-mediated increase in EPSC activity. These data also
strongly argue against the idea that the increase in sEPSC amplitude evoked by Hcrt/Orx could have resulted from a change in
ionotropic glutamate receptors because the amplitude distribution of the mEPSCs remained unaltered by Hcrt/Orx.
To determine the extent to which spontaneous action potentials
contributed to resting transmitter release in these slices, we examined the effect of TTX alone on sEPSC amplitude and interval
distributions. Application of TTX (0.5 M) had no net effect on
spontaneous EPSCs. The mean sEPSC amplitude before TTX
application was ⫺22.3 ⫾ 5.3 pA, and the mean mEPSC amplitude
after TTX was ⫺22.2 ⫾ 5.3 pA (n ⫽ 4; p ⫽ 0.86). Similarly, the
mean interval was 447.2 ⫾ 112.9 msec before TTX and 458.9 ⫾
122.2 msec after TTX (n ⫽ 4; p ⫽ 0.82). This indicated that the
resting frequency of sEPSCs did not significantly depend on
the firing of action potentials in these slices and suggests that the
increase in sEPSC frequency produced by Hcrt/Orx mainly results from the initiation of TTX-sensitive action potentials in
glutamatergic inputs to LDT neurons.

Hcrt/Orx enhanced evoked EPSCs
To determine whether Hcrt/Orx could influence action potentialevoked synaptic transmission in addition to its ability to stimulate
action potentials in afferents to the LDT, we examined the effect
of Hcrt/Orx-A (300 nM) on evEPSCs. Amplitude distributions of
30 –50 consecutive evEPSCs, evoked by near-minimal electrical
stimuli were compared before and after application of Hcrt/Orx
using Kolmogorov–Smirnov statistics. As expected, Hcrt/Orx-A
produced a small inward current in these neurons (Fig. 5A).
Coincident with this slow inward current was a significant increase in the mean evEPSC amplitude in three of five neurons
tested (mean amplitude, 147.74 ⫾ 6.5% of control; n ⫽ 3). This
increase in EPSC amplitude was reversible and recovered as the
inward current subsided (Fig. 5B). These data indicate that Hcrt/
Orx also enhanced spike-evoked EPSCs in LDT neurons.

The Hcrt/Orx-evoked inward current was accompanied
by an increase in membrane noise and conductance
and was not dependent on extracellular calcium
We further investigated the inward current by monitoring membrane conductance during application of Hcrt/Orx-A (300 nM and
1 M). Conductance was measured as the change in current
produced by constant voltage steps (1 sec duration; ⫺60 to ⫺90 or
⫺100 mV) delivered in the presence of TTX (1 M), DNQX (15
M), APV (50 M), bicuculline (10 M), and strychnine (2.5 M)
(Fig. 6 A, inset). Under these conditions, Hcrt/Orx produced an
inward current that was accompanied by an increase in membrane
noise and an increase in conductance (Fig. 6 A). Initially, the
inward current, noise, and conductance increased in parallel,
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Figure 4. TTX blocked the Hcrt /Orxevoked increase in EPSC frequency and
amplitude. Frequency and amplitude
distributions of mEPSC s were measured
in the presence of extracellular TTX
(0.5 M), bicuculline (10 M), and
strychnine (2.5 M) from recordings obtained using a K-gluconate (n ⫽ 4) or a
KC l (n ⫽ 5) internal solution. A, Raster
display of five consecutive samples of
membrane
current
[K-gluconate
(KGlu)] from before (lef t) and after
(right) application of 1 M Hcrt /Orx.
Hcrt /Orx evoked an inward shift in
membrane current and a large increase
in membrane noise but failed to alter
mEPSC activity, as indicated by the cumulative distributions of amplitude
(lef t) and interval (right). Control (thin
line) and Hcrt /Orx (thick line) distributions were not different, as indicated by
the p values from the Kolmogorov–
Smirnov test. B, Similar data set from
another LDT neuron recorded using the
internal KC l solution. Hcrt /Orx at 1 M
had no effect on membrane current or
noise, allowing unimpeded detection of
small EPSC s. Under these conditions,
Hcrt /Orx also had no effect on mEPSC
activity, as indicated by the cumulative
distributions of amplitude (lef t) and interval (right). C, Summary data indicating that TTX blocked both the change in mean mEPSC amplitude
(black bars) and interval (white bars) produced by Hcrt /Orx (1 M) when neurons were recorded with either internal solution.

Figure 5. Hcrt/Orx increased the amplitude of
evoked EPSCs. Neurons were recorded with a
K-gluconate internal solution and an extracellular solution containing bicuculline (10 M) and strychnine
(2.5 M). EPSCs in LDT neurons were evoked by
local electrical stimulation at 0.02 Hz. An Hcrt/Orx
superfusion produced the characteristic inward shift
in holding current. Epochs marked a, b, and c indicate
the control, Hcrt/Orx, and recovery conditions used to
compare EPSCs. Broken line indicates time between
data files. B, Averages of 50 consecutive EPSCs from
the epochs a–c indicated in A. The average amplitude
increased from 31 ( a) to 41 ( b) pA after the application of Hcrt/Orx and recovered as the Hcrt/Orx effect
on membrane current subsided ( c).

although the conductance increase was rather variable in magnitude. At the peak of the noise increase, the membrane conductance ranged from 105.2 to 178.3% of control (mean, 133.6 ⫾
10.1%; n ⫽ 9; p ⬍ 0.005). In some cases, the Hcrt/Orx-evoked
inward current and noise peaked and then began to subside (Fig.
6 A), whereas in others, the inward current remained elevated.
The conductance typically remained elevated for the duration of
the recording period. The average time course of these effects is
illustrated in Figure 6 B ( filled symbols) (n ⫽ 9). To determine
whether these prolonged actions were specifically related to Hcrt/
Orx actions, we conducted control experiments under identical
conditions (n ⫽ 4) but with Hcrt/Orx omitted from the superfusate (Fig. 6 B, open symbols). Comparison of these control data to
the Hcrt/Orx data verified that the observed changes were produced by Hcrt/Orx and were not an artifact of the lengthy recording period. To determine whether the conductance change recovered, we measured membrane conductance from cells that were
freshly patched an average of 49 min after Hcrt/Orx was applied

and compared this with the conductance measured from neurons
not yet exposed to Hcrt/Orx. Average membrane conductance
was not different between these groups (3.2 ⫾ 0.2 vs 4.0 ⫾ 0.4 nS;
n ⫽ 34; p ⬎ 0.05). Because we confirmed that these cells responded to a second application (and hence responded to the first
application), we conclude that the conductance change evoked by
Hcrt/Orx does recover, albeit slowly.
The finding that Hcrt/Orx increased both the membrane noise
and conductance suggested that the inward current might result,
in part, from the opening of “noisy” ion channels having a
relatively positive reversal potential. Consistent with this idea, we
observed that, after Hcrt/Orx application, membrane hyperpolarization to ⫺90 mV, which would increase the driving force for
such channels, produced greater membrane noise than observed
at ⫺60 mV. The increase in membrane noise associated with a
voltage jump from ⫺60 to ⫺90 mV was 2.7 times larger after
Hcrt/Orx application ( p ⬍ 0.05; n ⫽ 7).
The previous data suggested that the Hcrt/Orx effects may

2868 J. Neurosci., April 1, 2002, 22(7):2862–2872

Burlet et al. • Hcrt/Orx Control of REM Sleep-Related Neurons

Figure 6. Hcrt/Orx-evoked inward current and noise were associated with an
increase in membrane conductance. A,
Membrane current noise ( filled triangles)
and average membrane current ( filled circles) were monitored at a holding potential of ⫺60 mV, and input conductance
( filled squares) was monitored with voltage jumps to ⫺90 mV in the presence of a
solution (TTX, DABS) containing TTX
(0.5 M), DNQX (15 M), APV (50 M),
bicuculline (10 M), and strychnine (2.5
M) to eliminate action potentials and fast
synaptic activity. Under these conditions,
1 M Hcrt/Orx-A still evoked an increase
in noise and an inward current. These
changes were accompanied by a slow increase in membrane conductance. The inset illustrates membrane voltage (top) and
current (bottom) during a voltage jump
from before and after Hcrt/Orx application as indicated by the arrows. Voltage
and current calibration bars are 30 mV
and 50 pA, respectively, and the time calibration is 1 sec. B, Time course of mean ⫾ SEM membrane noise (Irms; triangles), current (Ibase; circles), and
conductance (Gm; squares) around the time of Hcrt/Orx application ( filled symbols; n ⫽ 9) or control solution application (open symbols; n ⫽ 4).
Hcrt/Orx, but not the control solution, produced changes in these measures. *p ⬍ 0.001 and #p ⬍ 0.05 indicate significantly different from control as
determined by a repeated-measures ANOVA and post hoc testing (Bonferroni).

result from activation of Hcrt/Orx receptors located on the recorded neurons. To further test this possibility, we lowered extracellular calcium to inhibit synaptic transmission. The lowcalcium ACSF completely abolished electrically evoked EPSCs
(Fig. 7A, inset). Nevertheless, Hcrt/Orx-A (300 nM) still evoked an
inward current (⫺32.8 ⫾ 10.6 pA; n ⫽ 8) that was accompanied
by an increase in membrane noise (186.8 ⫾ 31.3% of control; n ⫽
8) as illustrated for a single case in Figure 7A. The average
current magnitude and membrane noise evoked by Hcrt/Orx-A in
normal and low calcium solutions are summarized in Figure 7B
and were not statistically different ( p ⫽ 0.58, current; p ⫽ 0.15,
noise). These data demonstrate that neither calcium-dependent
currents nor synaptic transmitter release are necessary for these
Hcrt/Orx-A actions. Collectively, these findings suggest that both
the inward current and membrane noise arose from activation of
Hcrt/Orx receptors on LDT neurons.

Hcrt/Orx had similar actions on both bNOS-positive
and -negative LDT neurons
As indicated in Materials and Methods, we used bNOS immunofluorescence as a marker for cholinergic neurons to determine
whether the recorded neurons filled with biocytin were cholinergic. Fifty-six of 75 filled neurons were recovered, and most were
bNOS ⫹ (33 of 56), whereas the remainder (23 of 56) appeared
immunonegative (bNOS ⫺). These bNOS neurons were found in
the same focal plane with other bNOS ⫹ somata and processes,
suggesting that the lack of label was not a result of poor antibody
penetration. Because most cells responded to Hcrt/Orx, we compared the magnitude of the responses between immunopositive
and immunonegative neurons. No statistically meaningful differences were observed between these groups, whose data are summarized in Table 1. A one-way ANOVA confirmed there were no
statistical differences between responses obtained from bNOS ⫹,
bNOS ⫺, and the remaining neurons, which were not recovered.

Hcrt/Orx produces prolonged firing of LDT neurons in
the absence of fast synaptic potentials
Finally, because the inward current evoked by Hcrt/Orx was
rather small, it was unclear whether it would be large enough to

produce spiking without the associated increase in excitatory
synaptic drive. We therefore performed additional loose-patch
extracellular recordings during blockade of fast synaptic activity
with antagonists to ionotropic glutamate, GABA, and glycine
receptors. Under these conditions, Hcrt/Orx-A (300 nM) still
produced a prolonged increase in firing of all of the cells tested
(n ⫽ 9) (Fig. 8 A). Hcrt/Orx increased baseline firing rate from
0.23 ⫾ 0.1 spikes/sec to an average peak value of 1.03 ⫾ 0.22
spikes/sec (n ⫽ 9) and induced firing in three cells that had no
spontaneous action potentials before Hcrt/Orx application. Thus,
the postsynaptic actions alone of Hcrt/Orx were sufficient to drive
firing in these LDT neurons. We also verified that the increase in
spiking produced by Hcrt/Orx was dose dependent under these
conditions by allowing longer intervals than used previously between applications (Fig. 8 B). These data confirmed that concentrations of ⬎300 nM were saturating, as expected from dose–
response relationships in cells transfected with Hcrt/Orx
receptors (Sakurai et al., 1998; Smart et al., 1999). Indeed, the
average maximum firing rate evoked by 300 nM Hcrt/Orx was not
different from that evoked by 1 M Hcrt/Orx (1.02 ⫾ 0.22; n ⫽ 6;
p ⫽ 0.968).

DISCUSSION
Our findings demonstrated that Hcrt/Orx peptides influence mesopontine cholinergic neurons and suggests that these neurons
and their noncholinergic neighbors are normally under the excitatory influence of hypothalamic Hcrt/Orx neurons.

Actions of Hcrt/Orx on presynaptic neurons
A previous study, using cultured hypothalamic neurons, found that
Hcrt/Orx-B increased the frequency of mEPSCs and mIPSCs
recorded in the presence of TTX, suggesting that these peptides
can act on presynaptic terminals to increase release probability
(van den Pol et al., 1998). We found that both Hcrt/Orx-A and -B
increased the frequency of sEPSCs but that this effect was absent
in TTX, in all but one case. Because TTX alone had a negligible
effect on sEPSCs in resting slices, these findings suggest that
Hcrt/Orx triggered spiking in glutamatergic afferents, which in-
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Table 1. Hcrt/Orx had similar actions on bNOSⴙ and bNOSⴚ neurons
of the LDT
bNOS⫹

sEPSC interval
(% control)
sEPSC amplitude
(% control)
⌬Ibase (pA)
Irms (% control)

Figure 7. Hcrt/Orx-evoked inward current and membrane noise were
insensitive to lowering extracellular calcium. A, The increase in membrane noise (triangles) and inward current (circles) evoked by Hcrt/Orx-A
were resistant to solutions containing low extracellular calcium (Low
Ca2⫹, TTX, and DABS). Similar low Ca 2⫹ ASCF without TTX, DNQX,
and APV abolished evoked EPSCs (see inset). Calibration: 20 pA and 10
msec. Arrows point to membrane current traces from the indicated time
points before and after Hcrt/Orx application and illustrate the large noise
increase produced by Hcrt/Orx under these conditions. B, Summary of
mean inward current and noise evoked by 1 M Hcrt/Orx in calciumcontaining ACSF and by 300 nM Hcrt/Orx in low-calcium ACSF. The
responses were not statistically different. These data strongly indicate that
the inward current and membrane noise result from activation of Hcrt/
Orx receptors on LDT neurons.

creased the sEPSC frequency. This may have resulted from an
action of Hcrt/Orx on the somatodendritic, axonal, or terminal
regions of these glutamatergic afferents because it is not known
whether their somata are located within the slices. We also found
that Hcrt/Orx increased the amplitude of spike-evoked EPSCs.
Because Hcrt/Orx did not change the mEPSC amplitudes and
hence did not affect postsynaptic glutamate receptors, this effect
also resulted from an Hcrt/Orx action on presynaptic neurons.
This may have resulted from actions at the terminals to increase
release probability or from actions elsewhere to increase excitability of the presynaptic afferents.
Hcrt/Orx also increased the average sEPSC amplitude, an
effect also likely to result from actions of Hcrt/Orx on presynaptic
neurons. First, presynaptic action potentials evoked by Hcrt/Orx
would synchronize quanta released across multiple terminals aris-

bNOS⫺

t Test

Mean ⫾ SEM

n

Mean ⫾ SEM

n

p

54.0 ⫾ 7.0

11

34.8 ⫾ 10.4

4

0.17

130.2 ⫾ 8.1
⫺23.7 ⫾ 5.0
132.2 ⫾ 8.4

11
20
17

146.4 ⫾ 29.1
⫺25.0 ⫾ 4.8
144.1 ⫾ 11.4

4
9
9

0.62
0.85
0.41

Figure 8. The Hcrt/Orx-A-mediated current is sufficient to induce spiking in LDT neurons in the absence of fast PSPs. A, Hcrt/Orx-A at 300 nM
evoked repetitive firing in LDT neurons in the presence of a solution
(DABS) containing DNQX (15 M), APV (50 M), bicuculline (10 M),
and strychnine (2.5 M) to block fast glutamatergic, GABAergic, and
glycinergic transmission. This demonstrated that the relatively small current observed under whole-cell conditions is functionally sufficient to
produce suprathreshold depolarization in intact LDT neurons. B, Hcrt/
Orx-A-mediated excitation of LDT neurons was dose dependent. Hcrt/
Orx was applied during each 10 min epoch. Epochs were separated by the
indicated times. With sufficient time between doses, a concentrationdependent action was observed.

ing from single LDT afferents and also might release multiple
quanta from single terminals to produce larger sEPSCs. Second,
because Hcrt/Orx increased spike-evoked EPSCs, presynaptic
action potentials stimulated by Hcrt/Orx might be expected to
evoke larger EPSCs. Thus, Hcrt/Orx has one or more actions on
glutamatergic afferents that promote synaptic excitation of LDT
neurons.

Postsynaptic actions of Hcrt/Orx
Activation of heterologously expressed Hcrt/Orx receptors increases intracellular calcium primarily by release from intracellular stores (Sakurai et al., 1998; Smart et al., 1999). In cultured
hypothalamic neurons, Hcrt/Orx also elevated intracellular calcium but via a TTX-insensitive calcium influx, although no effect
on membrane current was observed (van den Pol et al., 1998). In
brain slices, Hcrt/Orx depolarized and evoked firing of locus
ceruleus (Horvath et al., 1999) and dorsal raphe neurons (Brown
et al., 2001), an effect associated with a decrease in membrane
conductance based on current-clamp recordings (Ivanov and
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Aston-Jones, 2000; Brown et al., 2001). In contrast, we found that,
in LDT neurons, Hcrt/Orx evoked an inward current associated
with increased membrane noise and conductance, effects not
reported previously. Moreover, the evoked current and noise did
not require significant activation of voltage-gated calcium channels because they were insensitive to low extracellular calcium,
which blocked synaptic transmission. These findings also indicate
that these effects resulted from activation of postsynaptic Hcrt/
Orx receptors.
The increase in membrane noise and conductance also suggested that channel openings were involved with generating the
inward current. Although other possibilities exist, the noise increase was reminiscent of the “noisy” cation current activated by
acetylcholine and norepinephrine in smooth muscle (Inoue and
Kuriyama, 1993; Wang et al., 1993) and by acetylcholine in
entorhinal cortex (Shalinsky et al., 2001). An alternative possibility that the noise resulted from regenerative currents in distal
dendrites seems unlikely. First, the increase in membrane noise
did not depend on known regenerative currents. Second, the
much larger sEPSCs did not trigger regenerative responses, even
during Hcrt/Orx activation. Finally, membrane hyperpolarization, which would have decreased regenerative dendritic events,
increased the current noise, an effect consistent with increasing
the driving force for cation channels. Thus, Hcrt/OrxRs may
activate a cation current similar to that observed in smooth
muscle or activated by peptides in other neurons (Aosaki and
Kawaguchi, 1996; Farkas et al., 1996; Kohlmeier and Reiner,
1999). Nevertheless, it appeared that more than a single ionic
mechanism was involved. In some cells, the inward current was
observed without increased membrane noise, and the current
often outlasted the noise increase. Moreover, the conductance
increase developed more slowly than either the noise increase or
inward current. These observations cannot be easily reconciled
with a single ionic mechanism, and additional work will be required to isolate the contributing factors.

Implications for wakefulness and narcolepsy
Mesopontine cholinergic neurons have extensive ascending and
descending projections with important targets in the thalamus
(for review, see Wainer and Mesulam, 1990), pontine reticular
formation (Mitani et al., 1988; Jones, 1990; Semba et al., 1990;
Semba, 1993), and midbrain dopamine regions (cf. Oakman et al.,
1995, 1999). It is well established that activating cholinergic
thalamic afferents produces EEG desynchronization (Curro
Dossi et al., 1991) by suppressing slow cortical waves (0.3–1 Hz),
delta waves (1– 4 Hz), and spindle wave oscillations (11–14 Hz)
(Hu et al., 1989; Steriade et al., 1993; Steriade, 1994). Stimulation
also promotes gamma band (20 – 40 Hz) oscillations (Steriade et
al., 1991) and fosters spatial coherence of these oscillations that
outlast stimulation of the mesopontine cholinergic nuclei (Steriade and Amzica, 1996; Steriade et al., 1996). Thus, Hcrt/Orx
activation of MPCh neurons is expected to promote EEG states
associated with the stimulus-dependent oscillations (gamma
waves) of arousal (Gray et al., 1990; Munk et al., 1996) and the
tonic EEG activation characteristic of waking and REM sleep.
Moreover, because cholinergic LDT neurons can drive dopamine
release in the nucleus accumbens by exciting ventral tegmental
area dopaminergic neurons (Forster and Blaha, 2000), Hcrt/Orxactivation of LDT should activate the limbic system and enhance
motivational components of arousal, as well.
Our findings, along with previous data (Ivanov and AstonJones, 2000; Brown et al., 2001), suggest that Hcrt/Orx neurons of
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the hypothalamus function to activate both monoamine and cholinergic components of the ascending reticular activating system
to promote EEG desynchronization and wakefulness. Indeed,
focal application of Hcrt/Orx in the locus ceruleus produces
arousal (Bourgin et al., 2000), and a similar effect has been
reported recently for Hcrt/Orx microinjections into the cat LDT
(Xi et al., 2001). Moreover, our finding that glutamatergic afferents to LDT neurons were strongly stimulated by Hcrt /Orx
suggest that Hcrt /Orx neurons provide excitatory input to
the glutamatergic neurons of the reticular core, as well. Thus,
hypothalamic Hcrt/Orx neurons may coordinate activation of the
entire ascending reticular activating system. Conversely, loss of
the Hcrt/Orx peptides in narcolepsy would be expected to disfacilitate the entire ascending reticular activating system and promote the excessive daytime sleepiness that is characteristic of this
disorder.
Considerable evidence also indicates that MPCh neurons play
an important role in generating REM sleep (for review, see
Steriade and McCarley, 1990) and that their projections to the
mPRF are of particular importance for this (Quattrochi et al.,
1989). Cholinergic stimulation of the mPRF rapidly produces a
REM-like state (Baghdoyan et al., 1984; Gnadt and Pegram,
1986), and, in narcoleptic dogs, muscarinic stimulation of this
region evokes cataplexy at doses that are benign in normals (Reid
et al., 1994a). Moreover, microdialysis of atropine into the mPRF
blocks the increase in attack frequency produced by systemic
administration of physostigmine, a cholinesterase inhibitor (Reid
et al., 1994a). Finally, Ach levels in the mPRF are elevated during
these attacks in narcoleptic dogs (Reid et al., 1994b), which, along
with the reported upregulation of mPRF muscarinic receptors in
the mPRF (Kilduff et al., 1986), suggests that exaggerated MPCh
transmission and an mPRF muscarinic supersensitivity promote
cataplexy.
Based on these findings, we initially hypothesized that Hcrt/
Orx would inhibit MPCh neurons and that the loss of such
inhibition in narcolepsy might explain the exaggerated MPCh
transmission in cataplexy. In contrast, our findings appear to rule
out this simple scheme and suggest that the loss of Hcrt/Orx input
would disfacilitate MPCh neurons. One consequence of a sustained disfacilitation of MPCh is that it might trigger the upregulation of postsynaptic muscarinic ACh receptors in the mPRF, as
suggested to account for muscarinic receptor changes in narcoleptic dogs (Kilduff et al., 1986). A second consequence, assuming
that exaggerated MPCh activity is required to provoke cataplexy,
is that one or more mechanisms must remain or be expressed in
the absence of Hcrt/Orx input to drive MPCh neuron activity
during these attacks. Because monoamines powerfully inhibit
MPCh neurons (Luebke et al., 1992; Williams and Reiner, 1993;
Leonard and Llinás, 1994), one possibility is that the loss of
Hcrt/Orx excitation to monoaminergic neurons produces a disinhibition of MPCh neurons that overpowers the disfacilitation
expected from the loss of Hcrt/Orx excitation. Consistent with
this is the observation that locus ceruleus activity ceases during
cataplectic episodes in the canine model (Wu et al., 1999). It is
anticipated that future physiological studies of mouse Hcrt/Orx
mutants will be of particular value in addressing this and other
possibilities.
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